- Home
- ALGS
as 12-20-2024 4:00pm EST
Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
| Founded: | 2018 | Country: | United States |
| Employees: | N/A | City: | SOUTH SAN FRANCISCO |
| Market Cap: | 118.8M | IPO Year: | 2020 |
| Target Price: | $75.00 | AVG Volume (30 days): | 425.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -12.89 | EPS Growth: | N/A |
| 52 Week Low/High: | $6.76 - $41.64 | Next Earning Date: | 11-06-2024 |
| Revenue: | $5,997,000 | Revenue Growth: | -63.40% |
| Revenue Growth (this year): | -75.4% | Revenue Growth (next year): | -64.40% |
Latest Aligos Therapeutics Inc. News
ALGS Breaking Stock News: Dive into ALGS Ticker-Specific Updates for Smart Investing
Simply Wall St.
5 hours ago
Aligos Therapeutics, Inc.'s (NASDAQ:ALGS) biggest owners are retail investors who got richer after stock soared 17% last week
GlobeNewswire
8 days ago
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
25 days ago
Aligos Therapeutics to Present at Investor Conferences in December
GlobeNewswire
a month ago
Aligos Therapeutics Presents Positive Data at The Liver Meeting (TLM) 2024
Simply Wall St.
a month ago
Aligos Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations
Zacks
a month ago
Aligos Therapeutics, Inc. (ALGS) Reports Q3 Loss, Tops Revenue Estimates
GlobeNewswire
a month ago
Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results
GlobeNewswire
2 months ago
Aligos Therapeutics to Announce 3rd Quarter 2024 Financial Results on November 6, 2024
Compare ALGS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ALGS Aligos Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.